Nine Point Two Capital LLC Tg Therapeutics, Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 39,170 shares of TGTX stock, worth $1.35 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
39,170Holding current value
$1.35 Million% of portfolio
0.27%Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
415Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$539 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$394 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$257 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$113 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$98.4 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.02B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...